Watch our International Myeloma Foundation webcasts by Saad Usmani, M.D., Assistant Professor of Medicine and Director of Developmental Therapeutics at the UAMS Myeloma Institute for Research and Therapy. 

ASH 2011: Dr. Usmani - Phase II Study of Carfilzomib (CFZ) Combined with Other Anti-Myeloma Agents in Relapsed-Refractory Multiple Myeloma (RRMM) - Updates on the UARK Compassionate Use Protocol

ASH 2011: Dr. Usmani - Second Malignancies in Total Therapy 3 Trials for Newly Diagnosed Multiple Myeloma: Influence of Lenalidomide Versus Thalidomide in Maintenance Phases

ASH 2011: Dr. Usmani - Implications of Serial Magnetic Resonance Imaging and Positron Emission Tomography Scanning for Survival of Untreated Myeloma Patients Treated with Total Therapy 3